These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 39774)

  • 1. [Homovanilic acid accumulation in the brain of rats as a possible cause of the inhibitory action of psychotropic substances on behavior and motor activity].
    Zharkovskiĭ AM; Allikmets LKh
    Farmakol Toksikol; 1979; 42(5):467-70. PubMed ID: 39774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central neurotropic activity of homovanillic acid.
    Kleinrok Z; Zarkowski AM
    Acta Physiol Pol; 1981; 32(5):477-85. PubMed ID: 7336983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship of the homovanillic acid content in the rat brain after the administration of a neuroleptic and the degree of dopamine receptor sensitivity to an agonist].
    Zharkovskiĭ AM; Allikmets LKh; Otter MIa
    Biull Eksp Biol Med; 1979 Jun; 87(6):559-60. PubMed ID: 572714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological analysis of the effect of homovanillic acid on rat behavior].
    Zharkovskiĭ AM; Klejnrok Z
    Farmakol Toksikol; 1981; 44(4):400-3. PubMed ID: 7286195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between some biochemical and behavioural effects produced by neuroleptics.
    Fregnan GB; Porta R
    Arzneimittelforschung; 1981; 31(1):70-4. PubMed ID: 6111328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive effects of cocaine on behavior and central amine metabolism in rhesus monkeys: relationship to kindling and psychosis.
    Post RM; Kopanda RT; Black KE
    Biol Psychiatry; 1976 Aug; 11(4):403-19. PubMed ID: 822887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seasonal changes in the behavioral effects of neuroleptics on white rats].
    Otter MIa; Kalda EI; Erik IuP
    Biull Eksp Biol Med; 1986 Nov; 102(11):577-9. PubMed ID: 2877693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of angiotensin II, its fragment and analogues.
    Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE
    Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.
    Ahtee L
    Br J Pharmacol; 1975 Nov; 55(3):381-5. PubMed ID: 1239323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical methods for predicting the occurrence of tardive dyskinesia.
    Bürki HR
    Commun Psychopharmacol; 1979; 3(1):7-15. PubMed ID: 38033
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity.
    Arribas E; Vega S; Benito C; Fernandez-Tome MP; del Rio J
    Arzneimittelforschung; 1983; 33(10):1417-21. PubMed ID: 6140017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine attenuates the locomotor sensitisation and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats.
    Banjaw MY; Fendt M; Schmidt WJ
    Behav Brain Res; 2005 May; 160(2):365-73. PubMed ID: 15863233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
    Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.